In the media: Genomeweb: Partial reimbursement for comprehensive DNA test in the Netherlands

This week, Genomeweb’s Precision Oncology News brought the news that the Dutch House of Representatives has recently unanimously decided to reimburse the comprehensive DNA testing for certain patient groups.

Read the article.

More information about the comprehensive DNA test.

You read an article in the category Billing code. You may also be interested in OncoAct.
All news

Also read

Healthcare providers share insights about GENAYA for young adult cancer patients 

Healthcare providers share insights about GENAYA for young adult cancer patients 

17-02-2025

In a series of short videos, our specialists share their insights on the GENAYA project. They explain what GENAYA is, …

Screening for T cells that already fight the tumor: Hartwig’s pipeline in practice 

Screening for T cells that already fight the tumor: Hartwig’s pipeline in practice 

16-07-2024

By Laura Nederveen   In the search for more effective cancer treatments, Alena Gros and her team at Vall d’Hebron Institute …

Hartwig receives CE certification for OncoAct, the first complete IVDR-certified whole-genome cancer diagnostics solution 

Hartwig receives CE certification for OncoAct, the first complete IVDR-certified whole-genome cancer diagnostics solution 

01-07-2026

We are proud to announce that Hartwig Medical Foundation has received CE certification under the European In Vitro Diagnostic Regulation …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl